Generic drug
Fentanyl price, strengths & recalls
Pharmacies pay $5,689.31 for 360 hs of Fentanyl 0.075 mg/hr (72 hr) patch this week, and from $87.97 to $20,766.96 across its 10 priced strengths and forms. 9 manufacturers make it. It is in shortage (unavailable). 22 recalls are ongoing. Its official label last changed on March 30, 2026.
Unavailable22 open recallsGeneric- Fair cash price
- $6,553.21
- Strengths
- 10
- Makers
- 9
- Updated
- Nov 11
Fentanyl price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.05 mg/mL, 2 mL injection | $1.76 | $87.97 / 50 mL |
| 0.05 mg/mL, 5 mL injection | $1.76 | $87.97 / 50 mL |
| 0.05 mg/mL, 50 mL injection | $1.76 | $87.97 / 50 mL |
| 0.012 mg/hr (72 hr) patch | $9.37 | $3,372.34 / 360 hs |
| 0.025 mg/hr (72 hr) patch | $6.07 | $2,184.98 / 360 hs |
| 0.0375 mg/hr (72 hr) patch | $36.19 | $13,027.63 / 360 hs |
| 0.05 mg/hr (72 hr) patch | $9.07 | $3,266.46 / 360 hs |
| 0.0625 mg/hr (72 hr) patch | $57.69 | $20,766.96 / 360 hs |
| 0.075 mg/hr (72 hr) patch | $15.80 | $5,689.31 / 360 hs |
| 0.1 mg/hr (72 hr) patch | $19.62 | $7,061.71 / 360 hs |
Supply status: shortages & recalls
Shortages
- Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)
- Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)
- Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
- Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)
- Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
- Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)Next release December 2026. Check wholesalers for inventory.
- Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)Check wholesalers for inventory
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)Next release December 2026. Check wholesalers for inventory.
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)Check wholesalers for inventory
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)Check wholesalers for inventory
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)Check wholesalers for inventory
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 356 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Fentanyl
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use FENTANYL CITRATE INJECTION safely and effectively. See full prescribing information for FENTANYL CITRATE INJECTION.Fentanyl Citrate Injection, for intravenous or intramuscular use, CIIInitial U.S. Approval: 1968
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM
USE OF FENTANYL CITRATE INJECTION
Addiction, Abuse, and Misuse
Because the use of Fentanyl Citrate Injection exposes patients and other users to the risks of opioid addiction, abuse and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)].
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of Fentanyl Citrate Injection, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Fentanyl Citrate Injection are essential [see Warnings and Precautions (5.2)].
Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS)
depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of Fentanyl Citrate Injection and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.4), Drug Interactions (7)].
Cytochrome P450 3A4 Interaction
The concomitant use of Fentanyl Citrate Injection with all cytochrome P450 3A4 inhibitors may result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in fentanyl plasma concentration. Monitor patients receiving Fentanyl Citrate Injection and any CYP3A4 inhibitor or inducer [see Warnings and Precautions (5.3), Drug Interactions (7), Clinical Pharmacology (12.3)]
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF FENTANYL CITRATE INJECTION
See full prescribing information for complete boxed warning.
Fentanyl Citrate Injection exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient's risk before prescribing and monitor regularly for these behaviors and conditions (5.1)
Serious, life-threatening, or fatal respiratory depression may occur with use of Fentanyl Citrate Injection, especially during initiation
or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Fentanyl Citrate Injection are essential. (5.2)
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. (5.3, 7)
Concomitant use with CYP3A4 inhibitors (or discontinuation of CYP3A4 inducers) can result in a fatal overdose of fentanyl. (5.4, 7, 12.3)
Recent major changes (as listed on the label)
Dosage and Administration (2.1) 12/2025
Warnings and Precautions (5.2, 5.3, 5.11) 12/2025
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA019101 · Hikma
- First approved
- July 11, 1984 (42 years ago)
- Latest approved change
- December 22, 2025
- Approved label
- PDF, Jan 6, 2026
- Generic makers
- 5 approved generic applications on the market
Fentanyl questions
How much does fentanyl cost without insurance?
Pharmacies pay about $5,689.31 for 360 hs of fentanyl 0.075 mg/hr (72 hr) patch ($15.80 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $6,553.21. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is fentanyl in shortage?
Yes. 20 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has fentanyl been recalled?
356 recalls on record, 22 ongoing. Recalls name specific lots - check yours.
When did the fentanyl label last change?
The official label was last updated on March 30, 2026 (version 13). See what changed.
Talk about fentanyl
No comments yet. Questions, tips, what worked for you - start the conversation.